Diabetes Insipidus, Neurogenic
Showing 1 - 25 of >10,000
Central Diabetes Insipidus (cDI) Trial in Basel (Intranasal OXT, Placebo nasal spray)
Not yet recruiting
- Central Diabetes Insipidus (cDI)
- Intranasal OXT
- Placebo nasal spray
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Endocrinology, Diabetes
Sep 6, 2023
Central Diabetes Insipidus Trial in Boston (Oxytocin nasal spray)
Not yet recruiting
- Central Diabetes Insipidus
- Oxytocin nasal spray
-
Boston, MassachusettsMassachusetts General Hospital, Neuroendocrine Unit
Apr 28, 2022
Arginine Vasopressin Deficiency, Primary Polydipsia Trial in Basel (Urea, Placebo)
Recruiting
- Arginine Vasopressin Deficiency
- Primary Polydipsia
- Urea
- Placebo
-
Basel, SwitzerlandUniversity Hospital Basel
Jun 6, 2023
Pituitary Adenoma, Pituitary Tumor, Diabetes Insipidus Cranial Type Trial in Leiden (Micro-electrode measurement)
Recruiting
- Pituitary Adenoma
- +3 more
- Micro-electrode measurement
-
Leiden, NetherlandsLeiden University Medical Center
Apr 13, 2022
Oxytocin Deficiency, Hypopituitarism, Hypothalamic Obesity Trial in Barcelona (Melatonin)
Not yet recruiting
- Oxytocin Deficiency
- +5 more
- Melatonin
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 31, 2022
Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: CRH administration, Control:
Recruiting
- Hypopituitarism
- +7 more
- Experimental: CRH administration
- Control: Placebo administration
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 18, 2022
Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: GLP1-RA (exenatide)
Recruiting
- Hypopituitarism
- +7 more
- Experimental: GLP1-RA (exenatide) administration
- Control: Placebo administration
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 18, 2022
Seoul National University Pituitary Disease Cohort Study
Recruiting
- Pituitary Disease
- +7 more
- Dynamic hormone study and Magnetic resonance imaging
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 17, 2020
Diabetes Insipidus, Polydipsia, Primary Trial in Worldwide (Arginine infusion, Hypertonic saline infusion)
Completed
- Diabetes Insipidus
- Polydipsia, Primary
- Arginine infusion
- Hypertonic saline infusion
-
Belo Horizonte, Brazil
- +6 more
Nov 30, 2022
Bipolar Disorder Trial (Anhydrous Amiloride Hydrochloride, Placebo)
Not yet recruiting
- Bipolar Disorder
- Anhydrous Amiloride Hydrochloride
- Placebo
- (no location specified)
May 16, 2022
Diabetes Insipidus Trial in Basel (study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), Control intervention:
Completed
- Diabetes Insipidus
- study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
- Control intervention: Placebo
-
Basel, SwitzerlandUniversity Hospital Basel, Endocrinology, Diabetes and Metabolis
Apr 12, 2022
Diabetes Insipidus Trial in Basel (Glucagon, Placebo)
Completed
- Diabetes Insipidus
- Glucagon
- Placebo
-
Basel, SwitzerlandDivison of Endocrinology, Diabetes and Metabolism,University Hos
May 18, 2022
Lithium Treated Patients
Not yet recruiting
- Lithium Toxicities
- +4 more
- Deamino Arginine Vasopressin (dDAVP)
-
Nijmegen, Gelderland, NetherlandsCanisius Wilhelmina Ziekenhuis
Mar 23, 2022
Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
- +3 more
-
Rochester, MinnesotaMayo Clinic Rochester
Feb 14, 2022
Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane
Recruiting
- Nephrogenic Diabetes Insipidus
-
Jette, Brussel, BelgiumUZ Brussel
Nov 3, 2021
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Their Correction in Heart and Lung Transplant Recipients and
Active, not recruiting
- Endocrine System Diseases
- +5 more
- Blood test
-
Budapest, Pest, HungaryHeart and Vascular Center
Jan 7, 2022
Neurogenic Bladder, Urinary Retention, Urologic Diseases Trial in Downey, San Diego, Washington (Connected Catheter)
Terminated
- Neurogenic Bladder
- +2 more
- Connected Catheter
-
Downey, California
- +2 more
Dec 28, 2022
Neurogenic Bladder, Multiple Sclerosis, Voiding Dysfunction Trial in Houston (Transcranial Rotating Permanent Magnet Stimulator
Active, not recruiting
- Neurogenic Bladder
- +2 more
- Transcranial Rotating Permanent Magnet Stimulator (TRPMS)
-
Houston, TexasHouston Methodist Hospital
Sep 3, 2021
Samsca Post-marketing General Drug Use-results Survey in
Recruiting
- Antidiuretic Hormone, Inappropriate Secretion
- Tolvaptan (SAMSCA)
-
Osaka, JapanPharmacovigilance Department
Apr 6, 2022
Lithium Use, Nephrogenic Diabetes Insipidus Trial in Montréal (Atorvastatin)
Completed
- Lithium Use, Nephrogenic Diabetes Insipidus
-
Montréal, Quebec, Canada
- +2 more
Sep 11, 2020
Response in Monosymptomatic Nocturnal Enuresis (MEN).
Completed
- Nocturnal Enuresis
- blood sampling
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Dec 10, 2021
Hypotension, Orthostatic Trial in Saint Petersburg, Upland, San Antonio (midodrine HCl (ProAmatine®))
Terminated
- Hypotension, Orthostatic
- midodrine hydrochloride (ProAmatine®)
-
Saint Petersburg, Florida
- +2 more
Jun 24, 2021
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023